Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study

BACKGROUND: Type 2 diabetes (T2D), with its prevalence and disability-causing nature, is a challenge for primary health care. Most patients with T2D are multimorbid, i.e. have one or more long-term diseases in addition to T2D. Multimorbidity may play a role in the achievement of T2D treatment target...

Full description

Bibliographic Details
Published in:BMC Health Services Research
Main Authors: Heikkala, Eveliina, Mikkola, Ilona, Jokelainen, Jari, Timonen, Markku, Hagnäs, Maria
Format: Text
Language:English
Published: BioMed Central 2021
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442281/
https://doi.org/10.1186/s12913-021-06989-x
id ftpubmed:oai:pubmedcentral.nih.gov:8442281
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:8442281 2023-05-15T18:07:41+02:00 Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study Heikkala, Eveliina Mikkola, Ilona Jokelainen, Jari Timonen, Markku Hagnäs, Maria 2021-09-14 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442281/ https://doi.org/10.1186/s12913-021-06989-x en eng BioMed Central http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442281/ http://dx.doi.org/10.1186/s12913-021-06989-x © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. CC0 PDM CC-BY BMC Health Serv Res Research Text 2021 ftpubmed https://doi.org/10.1186/s12913-021-06989-x 2021-09-19T00:50:15Z BACKGROUND: Type 2 diabetes (T2D), with its prevalence and disability-causing nature, is a challenge for primary health care. Most patients with T2D are multimorbid, i.e. have one or more long-term diseases in addition to T2D. Multimorbidity may play a role in the achievement of T2D treatment targets, but is still not fully understood. The aims of the present cross-sectional, register-based study were to evaluate the prevalence and the most common patterns of multimorbidity among patients with T2D; and to study the potential associations between multimorbidity and treatment goal achievement, including measurements of glycosylated haemoglobin A1c (HbA1c), low-density lipoprotein (LDL) and systolic blood pressure (sBP). METHODS: The study population consisted of 4545 primary care patients who received a T2D diagnosis between January 2011 and July 2019 in Rovaniemi Health Centre, Finland. Data on seven long-term concordant (T2D-related) diseases, eight long-term discordant (non-T2D-related) diseases, potential confounders (age, sex, body mass index, prescribed medication), and the outcomes studied were collected from patients’ records. Logistic regression models with odds ratios (ORs) and 95 % confidence intervals (CIs) were assessed to determine the associations between multimorbidity and the achievement of treatment targets. RESULTS: Altogether, 93 % of the patients had one or more diseases in addition to T2D, i.e. were considered multimorbid. Furthermore, 21 % had only concordant disease(s) (Concordant subgroup), 8 % had only discordant disease(s) (Discordant subgroup) and 64 % had both (Concordant and discordant subgroup). As either single diseases or in combination with others, hypertension, musculoskeletal (MS) disease and hyperlipidaemia were the most prevalent multimorbidity patterns. Being multimorbid in general (OR 1.32, CI 1.01–1.70) and belonging to the Concordant (OR 1.45, CI 1.08–1.95) and Concordant and discordant (OR 1.31, CI 1.00–1.72) subgroups was associated with achievement of the HbA1c ... Text Rovaniemi PubMed Central (PMC) Rovaniemi ENVELOPE(26.159,26.159,66.392,66.392) BMC Health Services Research 21 1
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Research
spellingShingle Research
Heikkala, Eveliina
Mikkola, Ilona
Jokelainen, Jari
Timonen, Markku
Hagnäs, Maria
Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study
topic_facet Research
description BACKGROUND: Type 2 diabetes (T2D), with its prevalence and disability-causing nature, is a challenge for primary health care. Most patients with T2D are multimorbid, i.e. have one or more long-term diseases in addition to T2D. Multimorbidity may play a role in the achievement of T2D treatment targets, but is still not fully understood. The aims of the present cross-sectional, register-based study were to evaluate the prevalence and the most common patterns of multimorbidity among patients with T2D; and to study the potential associations between multimorbidity and treatment goal achievement, including measurements of glycosylated haemoglobin A1c (HbA1c), low-density lipoprotein (LDL) and systolic blood pressure (sBP). METHODS: The study population consisted of 4545 primary care patients who received a T2D diagnosis between January 2011 and July 2019 in Rovaniemi Health Centre, Finland. Data on seven long-term concordant (T2D-related) diseases, eight long-term discordant (non-T2D-related) diseases, potential confounders (age, sex, body mass index, prescribed medication), and the outcomes studied were collected from patients’ records. Logistic regression models with odds ratios (ORs) and 95 % confidence intervals (CIs) were assessed to determine the associations between multimorbidity and the achievement of treatment targets. RESULTS: Altogether, 93 % of the patients had one or more diseases in addition to T2D, i.e. were considered multimorbid. Furthermore, 21 % had only concordant disease(s) (Concordant subgroup), 8 % had only discordant disease(s) (Discordant subgroup) and 64 % had both (Concordant and discordant subgroup). As either single diseases or in combination with others, hypertension, musculoskeletal (MS) disease and hyperlipidaemia were the most prevalent multimorbidity patterns. Being multimorbid in general (OR 1.32, CI 1.01–1.70) and belonging to the Concordant (OR 1.45, CI 1.08–1.95) and Concordant and discordant (OR 1.31, CI 1.00–1.72) subgroups was associated with achievement of the HbA1c ...
format Text
author Heikkala, Eveliina
Mikkola, Ilona
Jokelainen, Jari
Timonen, Markku
Hagnäs, Maria
author_facet Heikkala, Eveliina
Mikkola, Ilona
Jokelainen, Jari
Timonen, Markku
Hagnäs, Maria
author_sort Heikkala, Eveliina
title Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study
title_short Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study
title_full Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study
title_fullStr Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study
title_full_unstemmed Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study
title_sort multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study
publisher BioMed Central
publishDate 2021
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442281/
https://doi.org/10.1186/s12913-021-06989-x
long_lat ENVELOPE(26.159,26.159,66.392,66.392)
geographic Rovaniemi
geographic_facet Rovaniemi
genre Rovaniemi
genre_facet Rovaniemi
op_source BMC Health Serv Res
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442281/
http://dx.doi.org/10.1186/s12913-021-06989-x
op_rights © The Author(s) 2021
https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
op_rightsnorm CC0
PDM
CC-BY
op_doi https://doi.org/10.1186/s12913-021-06989-x
container_title BMC Health Services Research
container_volume 21
container_issue 1
_version_ 1766179910557106176